Effects of bilateral ovariectomy and postoperative hormonal replacement therapy with 17β-estradiol or raloxifene on serum leptin levels

Menopause

Volumn 10, Issue 2, 2003, Pages 160-164

  Tommaselli, Giovanni A ^a   Di Carlo, Costantino ^a   Nasti, Anna ^a   Giordano, Elena ^a   Pisano, Gustavo ^b   Pellicano, Massimiliano ^a   Bifulco, Giuseppe ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Estrogen replacement therapy; Leptin; Menopause; Ovariectomy; Raloxifene

Indexed keywords

ESTRADIOL; LEPTIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OVARIECTOMY; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; WEIGHT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; POSTOPERATIVE PERIOD;

ADMINISTRATION, CUTANEOUS; ADULT; BODY MASS INDEX; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEPTIN; OVARIECTOMY; POSTOPERATIVE PERIOD; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0037866739     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200310020-00008     Document Type: Article

References (23)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
2. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese women. N Engl J Med 1996;334:292-295.
3. Barash IA, Cheung CC, Weigle DS, et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144-3147.
4. Chehab FF, Lim ME, Lu R. Correction of sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318-320.
5. Slieker LJ, Sloop KW, Surface PL, et al. Regulation of ob m-RNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271: 5301-5304.
6. Kristiensen K, Pedersen SB, Richelsen B. Regulation of leptin by steroid hormones in rat adipose tissue. Biochem Biophys Res Commun 1999;259:624-630.
7. Machinal F, Dieudonne MN, Leneveu MC, Pecquery R, Guidicelli Y. In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 1999;140:1567-1574.
8. Di Carlo C., Tommaselli G.A., Nappi C. Leptin levels in the menopause. In: Studd J, ed. Management of the Menopause in the Millennium. Carnforth, UK: Parthenon Publishing Group, 1999:277-286.
9. Castracane VD, Kraemer RR, Franken MA, Kraemer GR, Gimpel T. Serum leptin concentration in women: effect of age, obesity, and estrogen. Fertil Steril 1998;70:472-477.
10. Kristiensen K, Pedersen SB, Vestergaard PV, Mosekilde L, Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 1999;163:55-62.
11. Gower BA, Nagy TR, Goran MI, Smith A, Kent E. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 2000;85:1770-1775.
12. Di Carlo C, Tommaselli GA, Pisano G, et al. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 2000;7:36-41.
13. Messinis IE, Milingos SD, Alexandris E, et al. Leptin concentrations in normal women following bilateral ovariectomy. Hum Reprod 1999;14:913-918.
14. Messinis IE, Kariotis I, Milingos S, Kollios G, Seferiadis K. Treatment of normal women with oestradiol plus progesterone prevents the decrease of leptin concentrations induced by ovariectomy. Hum Reprod 2000;15:2323-2327.
15. Khovidhunkit W, Shoback DM. Clinical effects of raloxifene hydrochloride in women. Ann Inter Med 1999;130:431-439.
16. Ettinger B, Black DM, Mitlak BH, Knickerbocker RH, Nickelsen T, Genant NK. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 1999;282: 637-645.
17. Walsh BW, Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998;279:1445-1451.
18. Cummings SR, Eckert S, Krueger KA, et al. Effects of raloxifene on breast cancer risk in postmenopausal women. JAMA 1999;281: 2189-2197.
19. Goldstein SR, Scheele WH, Rajagopalan SK, Wilkie JL, Walsh BW, Parsons AK. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol 2000;95:95-103.
20. Shimizu H, Shimomura Y, Nakanishi Y, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997;154:285-292.
21. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fired SK. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997;82:1635-1637.
22. Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997;82:414-417.
23. Norman RJ, Flight IHK, Rees MCP. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2002;2:CD001018.